Frozen shoulder trial opening more centres

Message from Professor Nanchahal (who was the person behind the RIDD trial) The Anti-Freaze-F trial of adalimumab for early-stage frozen shoulder is progressing, they are taking in patients in FOUR sites now! A high proportion (possibly around 50%) of people with Dupuytren’s disease also develop frozen shoulder. The trial now has 4 recruitment centres open, with another 2 in the process of opening (https://aff.octru.ox.ac.uk/sites-4). They will add the additional sites to the web page as soon as they open. the Anti-Freaze-F trial of adalimumab for early-stage frozen shoulder to the attention of your membership. The pain-predominant early stage of frozen shoulder only lasts about 3 months so we have a very short time window in which to enrol patients and administer the intervention. So if you think you are starting woth frozen shoulder, and you are near any of the centres (Conquest Hospital East Sussex, University Hospital Birmingham. Sandwell and West brimingham NHS Hospital, or United Lincolnshire Hospital), do consider asking your primary healthcare provider (GP) for referral to join the trial.